94189-8 |
APOA2 gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
APOA2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94189-8 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
APOA2 Full Mut Anl Bld/T Seq |
|
|
|
|
|
apoAII; Apo-AII; apolipoprotein A2; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.72 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9419-3 |
HLA-DQ6 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-DQ6 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
9419-3 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DQ6 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.73 |
1.0i |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
94190-6 |
BPGM gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
BPGM gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94190-6 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
BPGM Full Mut Anl Bld/T Seq |
|
|
|
|
|
bisphosphoglycerate mutase; Blood; Document; DPGM; ECYT8; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94191-4 |
BRCA1+BRCA2 gene deletion+duplication & full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
BRCA1+BRCA2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94191-4 |
|
Molgen |
|
|
Both |
|
|
|
0 |
BRCA1+BRCA2 Del+Dup + Full Mut Anl Bld/T |
|
|
|
|
|
Amplification; Ashkenazi jewish workup; Blood; BRCA; BRCC2; Breast cancer 2, early onset; BROVCA2; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; FACD; FAD; FAD1; FANCB; FANCD; FANCD1; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; GLM3; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; PNCA2; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; XRCC11 |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94192-2 |
SLC25A20 gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
SLC25A20 gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94192-2 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
SLC25A20 Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; CAC; CACT; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; solute carrier family 25 member 20; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94193-0 |
CDKN1C gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
CDKN1C gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94193-0 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
CDKN1C Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; BWCR; BWS; cyclin dependent kinase inhibitor 1C; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; KIP2; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; p57; p57Kip2; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; WBS; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94194-8 |
CPOX gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
CPOX gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94194-8 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
CPOX Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; coproporphyrinogen oxidase; COX; CPO; CPX; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; HCP; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94195-5 |
CPT2 gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
CPT2 gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94195-5 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
CPT2 gene Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; carnitine palmitoyltransferase 2; carnitine palmitoyltransferase 2 gene; carnitine palmitoyltransferase II gene; CPT1; CPTASE; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; IIAE4; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94196-3 |
CTRC gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
CTRC gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94196-3 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
CTRC Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; chymotrypsin C; CLCR; Document; ELA4; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94197-1 |
CYP21A2 gene deletion+duplication & full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
CYP21A2 gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94197-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
CYP21A2 Del+Dup + Full Mut Anl Bld/T |
|
|
|
|
|
21 Hydroxylase Deficiency; Amplification; Blood; CA21H; CAH1; Congenital adrenal hyperplasia; CPS1; CYP21; CYP21B; cytochrome P450, family 21, subfamily A, polypeptide 2; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; P450c21B; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94198-9 |
DPYD gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
DPYD gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.PHARMG |
|
94198-9 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
DPYD gene Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; DHP; DHPDHase; dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase gene; Dihydrothymine dehydrogenase gene; Dihydrouracil dehydrogenase gene; Document; DPD; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94199-7 |
FGA gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
FGA gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94199-7 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
FGA Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; Document; Fib2; fibrinogen alpha chain; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
942-3 |
Bombay Ag |
PrThr |
RBC |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Bombay Ag [Presence] on Red Blood Cells |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
942-3 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Bombay Ag RBC Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.61 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
9420-1 |
Entamoeba histolytica Ab |
Titr |
Ser |
Pt |
SemiQn |
Comp fix |
|
ACTIVE |
Entamoeba histolytica Ab [Titer] in Serum by Complement fixation |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
9420-1 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
E histolyt Ab Titr Ser CF |
|
|
|
Y |
|
ABS; Aby; Ameba; Amebiasis; Amebic; Amoeba; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); E histolyt; E histolytica; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0i |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
94200-3 |
FTCD gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
FTCD gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94200-3 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
FTCD Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; Document; Finding; Findings; formimidoyltransferase cyclodeaminase; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; LCHC1; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94201-1 |
GNPTAB gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
GNPTAB gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94201-1 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
GNPTAB Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; GNPTA; Heredity; Heritable; high-throughput sequencing; HTS; ICD; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; N-acetylglucosamine-1-phosphate transferase subunits alpha and beta; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94202-9 |
GRHPR gene deletion+duplication & full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
GRHPR gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94202-9 |
|
Molgen |
|
|
Both |
|
|
|
0 |
GRHPR Del+Dup + Full Mut Anl Bld/T |
|
|
|
|
|
Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; GLXR; GLYD; glyoxylate reductase/hydroxypyruvate reductase; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; PH2; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94203-7 |
GSN gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
GSN gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94203-7 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
GSN Full Mut Anl Bld/T Seq |
|
|
|
|
|
ADF; AGEL; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; gelsolin; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94204-5 |
HMBS gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
HMBS gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94204-5 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
HMBS Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; hydroxymethylbilane synthase; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; PBGD; PBG-D; Point in time; PORC; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; UPS; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94205-2 |
LYZ gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
LYZ gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94205-2 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
LYZ Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; lysozyme; LYZF1; LZM; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94206-0 |
MMACHC gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
MMACHC gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94206-0 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
MMACHC Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; metabolism of cobalamin associated C; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94207-8 |
MMADHC gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
MMADHC gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94207-8 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
MMADHC Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; C2orf25; cblD; CL25022; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; metabolism of cobalamin associated D; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94208-6 |
MLYCD gene deletion+duplication & full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Molgen |
|
ACTIVE |
MLYCD gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94208-6 |
|
Molgen |
|
|
Both |
|
|
|
0 |
MLYCD Del+Dup + Full Mut Anl Bld/T |
|
|
|
|
|
Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; Inherited; malonyl-CoA decarboxylase; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94209-4 |
NAGLU gene full mutation analysis |
Find |
Bld/Tiss |
Pt |
Doc |
Sequencing |
|
ACTIVE |
NAGLU gene full mutation analysis in Blood or Tissue by Sequencing |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
94209-4 |
|
Sequencing |
|
|
Both |
|
|
|
0 |
NAGLU Full Mut Anl Bld/T Seq |
|
|
|
|
|
Blood; CMT2V; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; MPS3B; MPS-IIIB; Mut; Mutations; N-acetyl-alpha-glucosaminidase; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; UFHSD; WB; Whole blood; Whole blood or Tissue |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9421-9 |
Entamoeba histolytica Ab |
ACnc |
Ser |
Pt |
Qn |
Immune diffusion |
|
ACTIVE |
Entamoeba histolytica Ab [Units/volume] in Serum by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
9421-9 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
E histolyt Ab Ser ID-aCnc |
|
|
|
Y |
|
ABS; Aby; Ameba; Amebiasis; Amebic; Amoeba; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; E histolyt; E histolytica; ID; Imm; Immunodiff; Immunodiffusion; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0i |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |